Fulcrum Therapeutics Inc (FULC) Annual Income Statement (USD)
FULC Quarterly Financials (USD)
Frequently Asked Questions About Fulcrum Therapeutics Inc (FULC) Stock
Fulcrum Therapeutics Inc's (FULC) last reported annual revenue was USD 2.81 Million.
Fulcrum Therapeutics Inc's (FULC) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Fulcrum Therapeutics Inc's(FULC) is not profitable as of its last reported annual financials.
The net profit margin for Fulcrum Therapeutics Inc's(FULC) from its laster reported year is -3470.05%
The return on equity (ROE) for Fulcrum Therapeutics Inc's(FULC) from its last reported annual financials is : N/A
The return on assets (ROA) for Fulcrum Therapeutics Inc's(FULC) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for Fulcrum Therapeutics Inc's(FULC) from its last reported annual financials is : N/A
The Debt to Equity ratio for Fulcrum Therapeutics Inc's(FULC) from its last reported annual financials is : N/A
The dividend yield for Fulcrum Therapeutics Inc's(FULC) from its laster reported year is N/A
Fulcrum Therapeutics Inc's(FULC) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for FULC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
